Missouri Becomes the Latest Battleground in the Fight Over ‘High’-Producing Hemp Products

The Fight Over ‘High’-Producing Hemp Products Moves to Missouri as the Latest Battleground

An issue with marijuana law is causing a dispute in Missouri, where state officials have recalled over 45,000 marijuana products made from hemp derivatives. The state Division of Cannabis Regulation (DCR) revoked the marijuana manufacturing license of Delta Extraction for importing marijuana from out-of-state sources and selling it along with Missouri-grown marijuana. The regulator also stated that the Delta products violated other rules.

Delta admitted to purchasing material from other states, but claimed that the imports were hemp-derived THC-A, a synthetic compound made from hemp that can be used to create high-producing delta-9 products. The company argued that because hemp is legal federally, the state has no justification for blocking the products.

The DCR also expressed safety concerns, stating that regulators could not ensure the imported material was properly tested, and claimed that Delta falsified product tracking records. Delta was also charged with failing to maintain proper surveillance footage or have necessary safeguards to prevent break-ins at the company’s production facility.

Originally, the state ordered a recall of over 62,000 products on August 14, but later reduced that to 45,000 products. The fate of these products will be debated before the Administrative Hearing Commission in December, when Delta’s appeal on its license revocation is also expected to be heard. Stakeholders say the outcome could mean steep financial losses for dozens of marijuana businesses if the products must be destroyed.

In appealing its license revocation, Delta argues that Missouri didn’t specifically ban adding hemp-derived THC-A to marijuana products until the state’s final rules went into effect on July 30. Chuck Hatfield, attorney for Delta Extraction, said the DCR never communicated that adding THC-A from hemp was against the rules until the company’s license was suspended in August.

Hatfield said Delta intends to challenge the CDR’s authority to regulate hemp-derived products, but the courts won’t accept a legal challenge against the state until the appeal process over the revocation of Delta Extraction’s license is completed.

In a similar situation, a federal judge in Arkansas last month granted a preliminary injunction against that state, ruling that hemp-derived cannabinoids, like THC-A, are protected under the 2018 Farm Bill.

State and local authorities across the country are working to regulate synthetically made, hemp-derived cannabinoids that produce a “high,” which are not regulated by the Food & Drug Administration (FDA). The products have proliferated in convenience stores and other common retail outlets, where they are marketed to youth in packaging that often mimics well-known brands of snacks and candy. Many producers and sellers have received warnings from the FDA regarding the safety of their products.

The matter may be addressed in the 2023 Farm Bill after the 2018 version of that measure failed to account for such downstream substances, which are usually made from CBD, a natural hemp derivative.

The U.S. Drug Enforcement Administration (DEA) has indicated it intends to change federal drug-control laws to ban highly concentrated synthetic THC products. The drug agency said in February that the products do not meet the federal definition of hemp and are therefore controlled substances.

Even some in the hemp business have suggested that the 2018 Farm Bill never intended hemp to be used to make psychoactive compounds and have criticized nefarious players they say are exploiting the 2018 Farm Bill’s language to sell highly potent synthetic THC products that are often rife with contaminants and inaccurately labeled.

Producers have argued that because the 2018 Farm Bill made hemp and its downstream products legal, THC-A, delta-8 and other such hemp-derived substances are therefore also legal. In a strict interpretation of the 2018 Farm Bill, the U.S. Court of Appeals for the Ninth Circuit agreed last year, noting that federal lawmakers can correct that situation with further legislation.

Producers started making synthetic psychoactive products from hemp amid the drastically diminished fortunes of the CBD sector, where demand did not reach inflated expectations and oversupply caused prices to plunge by as much as 90% over the past four years. Some analysts have said at least 75% of the current supply of CBD is going into the production of unregulated hemp-derived, high-producing products.

Subscribe to the website by e-mail

If you don't want to miss our updates let us notify you by email! Enter your email address to subscribe to this blog and receive notices of new posts.

Join 1 other subscriber

We will be happy to hear your thoughts

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Compare items
  • Total (0)